Sana Klinikum Offenbach GmbH — Offenbach, Hesse

Public research footprint of Sana Klinikum Offenbach GmbH, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer Metastatic · Vertebral Compression Fracture · Ovarian Cancer

Recently updated registry entries

NCT03647878 — Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With… (Active Not Recruiting)
NCT05958121 — IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid… (Recruiting)
NCT05882734 — Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sana Klinikum Offenbach GmbH?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.